Company intelligence / Profile preview

Avalite Sciences

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Avalite Sciences is a San Diego-based biotechnology company focused on developing novel small molecule inhibitors for oncology. The company was founded on the research of Dr. David Cheresh, a pioneer in integrin biology, and is backed by Avalon BioVentures. Avalite's primary mission is to target integrins alpha-V beta-3 and alpha-V beta-5, which are critical drivers of tumor angiogenesis, metastasis, and immune evasion. By developing highly potent and selective oral inhibitors, the company seeks to provide new treatment options for patients with refractory solid tumors.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Avalite Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avalite Sciences.

Explore the full profile